Mostaghim Mona, Snelling Thomas, Bajorek Beata
Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia.
Department of Pharmacy, Sydney Children's Hospital, Randwick, Sydney, NSW, Australia.
Int J Pharm Pract. 2019 Apr;27(2):180-190. doi: 10.1111/ijpp.12486. Epub 2018 Oct 3.
Assess restricted antimicrobials acquired after standard working hours for adherence to antimicrobial stewardship (AMS) and identify factors associated with increased likelihood of adherence at the time of acquisition, and the next standard working day.
All documented antimicrobials acquired from a paediatric hospital after-hours drug room from 1 July 2014 to 30 June 2015 were reconciled with records of AMS approval, and documented AMS review in the medical record.
Of the 758 antimicrobial acquisitions from the after-hours drug room, 62.3% were restricted. Only 29% were AMS adherent at the time of acquisition, 15% took place despite documented request for approval by a pharmacist. Antimicrobials for respiratory patients (OR 3.10, 95% CI 1.68-5.5) and antifungals (2.48, 95% CI 1.43-4.30) were more likely to be AMS adherent. Half of the acquisitions that required review the next standard working day were adherent to AMS (51.8%, 129/249). Weekday acquisitions (2.10, 95% CI 1.20-3.69) and those for patients in paediatric intensive care (2.26, 95% CI 1.07-4.79) were associated with AMS adherence. Interactions with pharmacists prior to acquisition did not change the likelihood of AMS adherence the next standard working day. Access to restricted antimicrobial held as routine ward stock did not change the likelihood of AMS adherence at the time of acquisition, or the next standard working day.
Restricted antimicrobials acquired after-hours are not routinely AMS adherent at the time of acquisition or the next standard working day, limiting opportunities for AMS involvement.
评估标准工作时间后获取的受限抗菌药物对抗菌药物管理(AMS)的依从性,并确定获取时及下一个标准工作日与依从性增加可能性相关的因素。
对2014年7月1日至2015年6月30日从儿科医院非工作时间药房获取的所有已记录抗菌药物与AMS批准记录以及病历中记录的AMS审查进行核对。
在从非工作时间药房获取的758例抗菌药物中,62.3%为受限药物。获取时仅29%符合AMS要求,15%的获取发生在药剂师已记录要求批准的情况下。用于呼吸道疾病患者的抗菌药物(比值比3.10,95%置信区间1.68 - 5.5)和抗真菌药物(2.48,95%置信区间1.43 - 4.30)更有可能符合AMS要求。下一个标准工作日需要审查的获取病例中有一半符合AMS要求(51.8%,129/249)。工作日获取(2.10,95%置信区间1.20 - 3.69)以及儿科重症监护患者的获取(2.26,95%置信区间1.07 - 4.79)与AMS依从性相关。获取前与药剂师的互动并未改变下一个标准工作日AMS依从的可能性。获取作为常规病房库存的受限抗菌药物并未改变获取时或下一个标准工作日AMS依从的可能性。
非工作时间获取的受限抗菌药物在获取时或下一个标准工作日通常不符合AMS要求,限制了AMS参与的机会。